Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Emergent Biosolutions (EBS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,245,897
  • Shares Outstanding, K 50,945
  • Annual Sales, $ 560,870 K
  • Annual Income, $ 82,590 K
  • 36-Month Beta 1.38
  • Price/Sales 4.62
  • Price/Cash Flow 23.28
  • Price/Book 3.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.41
  • Number of Estimates 1
  • High Estimate 0.41
  • Low Estimate 0.41
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +1,466.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.46 +9.87%
on 01/29/19
67.45 -4.77%
on 02/22/19
+3.40 (+5.59%)
since 01/22/19
3-Month
54.00 +18.94%
on 12/21/18
73.89 -13.07%
on 12/03/18
-6.53 (-9.23%)
since 11/21/18
52-Week
46.49 +38.17%
on 02/23/18
73.89 -13.07%
on 12/03/18
+14.84 (+30.05%)
since 02/22/18

Most Recent Stories

More News
Emergent (EBS) Q4 Earnings, Revenues Surpass Estimates

Emergent (EBS) rides high on both earnings and a revenue beat in Q4.

CELG : 89.06 (+0.46%)
EBS : 64.32 (+0.94%)
GSK : 40.48 (-0.15%)
SNY : 41.19 (-0.34%)
Emergent Biosolutions (EBS) Q4 Earnings and Revenues Surpass Estimates

Emergent Biosolutions (EBS) delivered earnings and revenue surprises of 22.95% and 0.63%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

EBS : 64.32 (+0.94%)
Emergent Biosolutions: 4Q Earnings Snapshot

GAITHERSBURG, Md. (AP) _ Emergent Biosolutions Inc. (EBS) on Thursday reported a fourth-quarter loss of $3.4 million, after reporting a profit in the same period a year earlier.

EBS : 64.32 (+0.94%)
Emergent BioSolutions Reports Fourth Quarter and Full Year 2018 Financial Results

Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter and year ended December 31, 2018.

EBS : 64.32 (+0.94%)
Factors of Influence in 2019, Key Indicators and Opportunity within CVS Health, Solaris Oilfield Infrastructure, SK Telecom Co., Energizer, Emergent Biosolutions, and Quad Graphics -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of CVS Health Corporation (NYSE:CVS),...

CVS : 61.69 (-1.06%)
QUAD : 15.71 (-2.24%)
SKM : 25.59 (+0.75%)
EBS : 64.32 (+0.94%)
ENR : 46.04 (-0.17%)
SOI : 16.16 (+1.25%)
Emergent BioSolutions Announces Appointment of Seamus Mulligan to its Board of Directors

Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Seamus Mulligan to the company's Board of Directors effective March 19, 2019. Mr. Mulligan was a co-founder and principal investor...

EBS : 64.32 (+0.94%)
Emergent BioSolutions to Release Fourth Quarter and Full Year 2018 Financial Results and Conduct a Conference Call on February 21, 2019

Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 21, 2019 at 5:00 pm (Eastern Time) to discuss the financial results for the fourth quarter and full year 2018, recent...

EBS : 64.32 (+0.94%)
Emergent BioSolutions Announces Appointment of Robert G. Kramer, Sr. to Its Board of Directors

Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Robert G. Kramer, Sr. to the company's Board of Directors. Mr. Kramer currently serves as Emergent's president and COO. Effective...

EBS : 64.32 (+0.94%)
Emergent (EBS) Up on '19 View, Posts Preliminary '18 Results

Emergent (EBS) provides preliminary results for 2018 and guidance for 2019. The results exceed estimates.

EBS : 64.32 (+0.94%)
VNDA : 20.93 (+4.49%)
GSK : 40.48 (-0.15%)
SNY : 41.19 (-0.34%)
Emergent (EBS) CEO Abdun Nabi to Retire, Kramer to Succeed

Emergent (EBS) names Robert G. Kramer, Sr. as its next chief executive officer, who will assume office from Apr 1, 2019 onward. He will succeed the incumbent CEO Daniel J. Abdun-Nabi.

GHDX : 82.10 (+4.79%)
EBS : 64.32 (+0.94%)
INO : 3.70 (-0.27%)
VNDA : 20.93 (+4.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade EBS with:

Business Summary

Emergent BioSolutions Inc. is strongly committed to the highest standards of ethical conduct and corporate governance. These standards are consistent with their corporate culture. The company understands that adhering to sound principles of corporate governance is critical to earning and maintaining...

See More

Key Turning Points

2nd Resistance Point 66.16
1st Resistance Point 64.94
Last Price 64.32
1st Support Level 62.93
2nd Support Level 62.14

See More

52-Week High 73.89
Last Price 64.32
Fibonacci 61.8% 63.42
Fibonacci 50% 60.19
Fibonacci 38.2% 56.95
52-Week Low 46.49

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar